v3.25.1
Segment Reporting
 3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Segment Reporting

12. Segment Reporting

The Company operates and is managed as a single operating segment. The measure of segment assets is reported on the consolidated balance sheets as total assets. All assets are in the United States and there has been no revenue generated through March 31, 2025. The accounting policies of the segment are the same as those described in Note 2.

The determination of a single operating segment is consistent with the consolidated financial information regularly reviewed by the CODM, which is used in assessing segment performance and deciding how to allocate resources on a consolidated basis. The CODM assesses segment performance and makes decisions on how to allocate resources based on consolidated net loss reported on the consolidated statements of operations and comprehensive loss. In assessing performance, the CODM reviews net loss in comparison to budget.

The following table presents information about reported significant segment expenses:

 

 

Three Months Ended March 31,

 

 

 

2025

 

 

2024

 

Research and development external expenses

 

 

 

 

 

 

Iluzanebart

 

$

3,469

 

 

$

3,661

 

Small molecule TREM2

 

 

4,791

 

 

 

3,703

 

Research and development - other

 

 

1,439

 

 

 

981

 

Total research and development external expenses

 

 

9,699

 

 

 

8,345

 

General and administrative external expenses

 

 

2,356

 

 

 

2,221

 

Facilities, personnel-related, and other

 

 

11,414

 

 

 

10,849

 

Loss from operations

 

 

(23,469

)

 

 

(21,415

)

Other income (expense), net

 

 

1,056

 

 

 

1,475

 

Net loss

 

$

(22,413

)

 

$

(19,940

)